Quality Improvement Bedside Rounding Audits Enhance Protein Provision for Pediatric Patients Receiving Continuous

Molly Wong Vega1, Marisa Juarez1, Ji Yeon Lee1

  • 1Section of Nephrology, Department of Pediatrics, Baylor College of Medicine, Houston, TX.

Insights

Quality improvement initiatives significantly enhanced protein delivery for pediatric patients undergoing continuous renal replacement therapy (CRRT). This study demonstrates improved protein goal achievement in critically ill children receiving CRRT.

Area of Science:

  • Pediatric Critical Care Medicine
  • Renal Replacement Therapy
  • Quality Improvement Science

Background:

  • Optimizing protein delivery is crucial for critically ill patients, especially those on continuous renal replacement therapy (CRRT).
  • Suboptimal protein delivery can lead to adverse outcomes in pediatric intensive care unit (PICU) patients.

Purpose of the Study:

  • To describe quality improvement process improvements in protein delivery during the initiation of CRRT.
  • To evaluate the impact of structured interventions on meeting protein goals in pediatric CRRT patients.

Main Methods:

  • A prospective study utilizing Plan-Do-Study-Act (PDSA) cycles in pediatric and cardiovascular intensive care units.
  • Interventions included establishing an interdisciplinary quality improvement group, bedside safety rounds, dedicated nutrition monitoring, intensivist education, and regular quality improvement meetings.
  • Outcomes measured were the percentage of time patients met protein goals within the first 5 days and throughout the duration of CRRT.

Main Results:

  • The percentage of time meeting protein goals by day 5 increased from 22% to 71% across the PDSA cycles.
  • Protein goal achievement throughout CRRT improved from 35% to 75%.
  • Significant improvements in both primary and secondary outcomes were observed after the third PDSA cycle (p < 0.01).

Conclusions:

  • Implementing an interprofessional quality improvement team effectively improved protein delivery in pediatric CRRT.
  • These quality improvement efforts led to a significant decrease in CRRT days with unmet protein goals.
Abstract

Related Concept Videos

Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
1.1K
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
225
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
266
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
314
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
237
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
305